Management of Hemophilia in France^[*]

Summary

Two important factors concerning the management of hemophilia in France are considered.

The supply of factors VIII and IX for replacement therapy meets the current demand but as the demand increases with the development of self-infusion programs, the production will also have to increase. This can only be done through more effective use of all of the blood components and will require careful evaluation of the needs of each patient.

Programs which teach self-infusion and the other aspects of home care are gradually allowing the hemophiliac and his family better understanding of the disease. These programs are developing slowly in France but must be expanded to improve the general care of all French hemophiliacs.

^* Presented at the Symposium held during the 3rd meeting of the European and African Division of the International Society of Haematology in London, August 1975.

• References

• 1 Allain J. P. 1975; A boarding school for hemophiliacs: A model for the comprehensive care of hemophilic children. Annals of the New York Academy of Sciences 240: 226.
• 2 Allain J. P, Estrabaut M, Tran J, and Gutton Ph. 1975; Traitement de l’hémophilie par l’autoperfusion. Etude clinique et psychologique. Nouvelle Revue Française d’Hématologie 15: 147.
• 3 Allain J. P, Gentil C, and Gutton Ph. 1975. Special schools for hemophiliacs. In: Brinkhous K. M, and Hemker H. C. (eds.) Handbook of Hemophilia. Excerpta Medica; Amsterdam: Part II 881.
• 4 Didisheim P, Loeb J, Blatrix C, and Soulier J. P. 1959; Preparation of a human plasma fraction rich in prothrombin, proconcertin, Stuart factor and PTC and a study of its activity and toxicity in rabbits and man. Journal of Laboratory and Clinical Medicine 53: 322.
• 5 Heystek J, Brummelhuis H. G. J, and Krijnen H. W. 1973; Contributions to the optimal use of human blood, II. The large scale preparation of prothrombin complex. A comparison between two methods using the anion exchangers DEAE-cellulose DE-52 and DEAE Sephadex A-50. Vox Sanguinis 25: 113.
• 6 Levine P. H, and Britten A. F. H. 1973; Supervised patient management of hemophilia. A study of 45 patients with hemophilia A and B. Annals of Internal Medicine 78: 195.
• 7 Newman J, Johnson A J, Karpatkin M. H, and Puszkin S. 1971; Methods for the production of clinically effective intermediate and high purity factor VIII concentrates. British Journal of Haematology 21: 1.